Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 4 51-4, 2005, Pages

  Graupera, Mariona ^a   March, Sandra ^a   Engel, Pablo ^a   Rodés, Juan ^a   Bosch, Jaume ^a   García Pagán, Joan Carles ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Hepatic cyclooxygenase expression; Nonparenchymal cells; Portal pressure; Selective cyclooxygenase inhibition

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; METHOXAMINE; PROSTANOID; THROMBOXANE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LOCALIZATION; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; KUPFFER CELL; LIVER BLOOD VESSEL; LIVER CELL; LIVER CIRRHOSIS; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; STELLATE CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM; HEPATOCYTES; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR; VASOMOTOR SYSTEM;

EID: 15244353838     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00300.2004     Document Type: Article

References (43)

1. Amann R, Schuligoi R, and Peskar BA. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung: Inflamm Res 50: 50-53, 2001.
2. Baber SR, Champion HC, Bivalacqua BS, Hyman AL, and Kadowitz PJ. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds. Circulation 108: 896-901, 2003.
3. Ballardini G, Groff P, Badiali DG, Schuppan D, and Bianchi FB. Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology 19: 440-446, 1994.
4. Ballet F, Chretien Y, Rey C, and Poupon R. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver. J Pharmacol Exp Ther 244: 283-289, 1988.
5. Bataller R, Gasull X, Gines P, Hellemans K, Gorbig MN, Nicolas JM, Sancho-Bru P, De Las HD, Gual A, Geerts A, Arroyo V, and Rodes J. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33: 956-962, 2001.
6. Bathal PS and Grossmann HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1: 325-329, 1985.
7. Calvo M, Tebar F, Lopez-Iglesias C, and Enrich C. Morphological and functional characterization of caveolae in rat liver hepatocytes. Hepatology 33: 1259-1269, 2001.
8. Camacho M and Vila L. Transcellular formation of thromboxane A(2) in mixed incubations of endothelial cells and aspirin-treated platelets strongly depends on the prostaglandin I-synthase activity. Thromb Res 99: 155-164, 2000.
9. Cassiman D, Libbrecht L, Desmet V, Denef C, and Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36: 200-209, 2002.
10. Crofford LJ. COX-1 and COX-2 tissue expression: .implications and predictions. J Rheumatol 24, Suppl 49: 15-19, 1997.
11. Dahl SV, Bode JG, Reinehr RM, Mönnighoff I, Kubitz R, and Häussinger D. Release of osmolytes from perfused rat liver on perivascular nerve stimulation: alpha-adrenergic control of osmolyte efflux from parenchymal and nonparenchymal liver cells. Hepatology 29: 195-204, 1999.
12. Davaille J, Gallois C, Habib A, Li L, Mallat A, Tao J, Levade T, and Lotersztajn S. Antiproliferative properties of sphingosine-1 -phosphate in human hepatic myofibroblast. A cyclooxygenase-2 mediated pathway. J Biol Chem 275: 34628-34633, 2000.
13. De la Fuente MA, Tovar V, Villamor N, Zapater N, Pizcueta P, Campo E, Bosch J, and Engel P. Molecular chracterization and expression of a novel human leukocyte- cell-surface marker homologous to mouse Ly-9. Blood 97: 3513-3520, 2001.
14. Denda A, Kitayama W, Murata A, Kishida H, Sasaki Y, Kusuoka O, Tsujiuchi M, Tsutsumi M, Nakae D, Takagi H, and Konishi Y. Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulfide. Carcinogenesis 23: 245-256, 2002.
15. Dijkstra CD, Dopp EA, Joling P, and Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophages subpopulation in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54: 589-599, 1985.
16. Duijvesteijn AM, van Goor H, Klatter F, Majoor GD, van Bussel E, and Van Breda Vriesman PJ. Antibodies defined rat endothelial cells: RECA-1 a pan-endothelial cell specific monoclonal antibody. Lab Invest 66: 459-466, 1992.
17. Efsen E, Bonacchi A, Pastacaldi S, Valente AJ, Wenzel UO, Tosti-Guerra C, Pinzani M, Laffi G, Abboud HE, Gentilini P, and Marra F. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 33: 713-721, 2001.
18. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, and Boulanger CM. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76: 1003-1010, 1995.
19. Geerts A, Niki T, Hellemans K, De Craemer D, Van Den Berg K, Lazou JM, Stange G, Van De Winkel M, and De Bleser P. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology 27: 590-598, 1998.
20. Graupera M, Garcia-Pagan JC, Abraldes JG, Peralta C, Bragulat M, Corominola H, Bosch J, and Rodes J. Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers. Hepatology 37: 172-181, 2003.
21. Graupera M, Garcia-Pagan JC, Pares M, Abraldes JG, Rosello J, Bosch J, and Rodes J. Cyclooxyenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers. J Hepatol 39: 515-521, 2003.
22. Graupera M, Garcia-Pagan JG, Titos E, Claria J, Massaguer A, Bosch J, and Rod SJ. 5-Lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinylleukotrienes. Gastroenterology 122: 387-393, 2002.
23. Grossman HJ, Grossman VL, and Bhathal PS. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood. J Gastroenterol Hepatol 7: 283-287, 1992.
24. Gupta TK, Toruner M, Chung MK, and Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28: 926-931, 1998.
25. Hendrickson RJ, Cappadona C, Yankah EN, Sitzmann JV, Cahill PA, and Redmond EM. Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells. J Mol Cell Cordiol 31: 619-629, 1999.
26. Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED, Soh JW, Weinstein IB, and Wong BC. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-269 through a protein kinase C-beta(1)-dependent pathway. Oncogene 21: 6113-6122, 2002.
27. Knittel T, Kobold D, Piseaglia F, Saile B, Neubauer K, Mehde M, Timpl R, and Ramadori G. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. Histochem Cell Biol 112: 387-401, 1999.
28. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, and Dey SK. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91: 197-208, 1997.
29. Lopez-Parra M, Claria J, Planaguma A, Titos E, Masferrer JL, Woerner BM, Koki AT, Jimenez W, Altuna R, Arroyo V, Rivera F, and Rodes J. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites. Br J Pharmacol 135: 891-900, 2002.
30. Marteau P, Ballet F, Chazouilleres O, Chretien Y, Rey C, Petit D, and Poupon R. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology 9: 820-823, 1989.
31. Martin M, Romero X, de la Fuente MA, Tovar V, Zapater N, Esplugues E, Pizcueta P, Bosch J, and Engel P. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J Immunol 167: 3668-3676, 2001.
32. Matz RL, Alvarez de Sotomayor M, Schott C, Stoclet JC, and Andriantsitohaina R. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br J Pharmacol 131: 303-311, 2000.
33. Munthe-Kaas AC, Berg T, Seglen PO, and Seljelid R. Mass isolation and culture of rat kupffer cells. J Exp Med 141: 1-10, 1975.
34. Naraba H, Murakami M, Matsumoto H, Shimbara S, Ueno A, Kudo I, and Oh-ishi S. Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol 160: 2974-2982, 1998.
35. Niki T, De Bleser PJ, Xu G, Van Den BK, Wisse E, and Geerts A. Comparison of glial fibrillary acidic protein and desmin staining in normal and CC14-induced fibrotic rat livers. Hepatology 23: 1538-1545, 1996.
36. Pinzani M and Gcntilirii P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 19: 397-410, 1999.
37. Potenza MA, Botrugno OA, De Salvia MA, Lerro G, Nacci C, Marasciulo FL, Andriantsitohaina R, and Mitolo-Chieppa D. Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats. Am J Physiol Gastrointest Liver Physiol 283: G587-G594, 2002.
38. Rockey DC and Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver, implications for regulation of portal pressure and resistance. Hepatology 24: 233-240, 1996.
39. Schorr K, Taimor G, Degenhardt H, Weber K, and Schlüter KD. Parathyroid hormone-related peptide is induced by stimulation of alpha1A-adrenoreceptor and improves resistance against apootosis in coronary endothelial cells. Mol Pharmacol 63: 111-118, 2003.
40. Tabernero A, Giraldo J, Vivas N, Badia A, and Vila E. Endothelial modulation of alpha 1-adrenorecptor contractile responses in the tail artery of spontaneously hypertensive rats. Br J Pharmacol 119: 765-771, 2003.
41. Ueno N, Murakami M, Tanioka T, Fujimori K, Tanabe T, Urade Y, and Kudo I. Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J Biol Chem 276: 34918-34927, 2001.
42. Xing M and Insel PA. Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells. J Clin Invest 97: 1302-1310, 1996.
43. Yokoyama Y, Xu H, Kresge N, Keller S, Sarmadi AH, Baveja R, Clemens MG, and Zhang JX. Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastroentest Liver Physiol 284: G453-G460, 2003.